Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation.
Academic Article
Overview
abstract
In this commentary, we summarize the most recent advances in the cytokine-targeting therapies. We focus on new aspects of interleukin-1 (IL-1)-mediated autoinflammation and novel strategies to target IL-1.
